title: Denosumab and fracture risk in women with breast cancer.
authors.affiliation: Department for Pharmacovigilance and Pharmacoepidemiology, Reims University Hospital, and University of Reims Champagne-Ardenne, Faculty of Medecine, Reims, France.
authors.forename: Paul
authors.initials: P
authors.lastname: de Boissieu
authors.affiliation: Department for Pharmacovigilance and Pharmacoepidemiology, Reims University Hospital, and University of Reims Champagne-Ardenne, Faculty of Medecine, Reims, France. Electronic address: ttrenque@chu-reims.fr.
authors.forename: Thierry
authors.initials: T
authors.lastname: Trenque
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000150:complications*; D005260:Female; D050723:Fractures, Bone; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized